About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
D
Overview of a SoC in 1L mRCC Focusing on the Long-Term Survival Data
By
David McDermott
3 Videos
222 views
May 10, 2024
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
International Urology Cancer Summit - IUCS
Second International Urology Cancer Summit
Fri, Sep 27, 2024
16:05
Insights from 2024 ASCO® GU Annual Meeting
Recent GU Developments and Their Clinical Implications
Feat.
T. Powles,
B. Rini
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
29:25
Northwestern Medicine Oncology and Hematology
Hyperprogression in Cancer Treated With Immunotherapy
Feat.
Y. Chae
13:37
SIR 2023 Conference Coverage
SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?
Feat.
N. Kothary
15:58
Total Health
Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024
Feat.
M. Reimers
10:19
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implicat…
Feat.
K. Mittal
07:27
Jason Levy
Opus One: Final Results - RFA in Axial Skeleton
15:28
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Bladder and RCC Highlights"
Feat.
K. Tawagi,
N. Reizine
06:58
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very…
Feat.
M. Zarba
19:41
Balazs Halmos
How I Manage Immune Adverse Events in Solid Tumors
22:03
Dana-Farber Cancer Institute
RCC Highlights From ASCO® GU 2024
Feat.
W. Xu,
T. Choueiri
17:33
Benjamin Garmezy
1L Treatment Approaches in aRCC: Current Data, Treatment Selection, …
06:49
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Belzutifan for Advanced Renal Cell Carcin…
Feat.
E. Jonasch
16:19
OncoAlert
Year in Review: RCC Practice Changing and Practice Informing Trials …
Feat.
T. Choueiri
09:54
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "1L Systemic Therapy Following Adjuvant IO…
Feat.
T. El Zarif
07:10
Viktor Grünwald
Updated Results From the CLEAR Trial: Outcomes of the Combination of…
09:54
Insights from 2024 ASCO® GU Annual Meeting
The Impact of Immunotherapy-Based Regimens in Primary Renal Tumors
Feat.
R. McKay
09:12
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Cabozantinib, Nivolumab, and Ipilimumab f…
Feat.
B. McGregor
19:30
Natalie Reizine
Recent Advances in Molecular-Guided Treatment of GU Malignancies
23:31
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Harnessing the Immune System in RCC - Cur…
Feat.
D. Braun
